Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International Continence Society best practice statement for use of sacral neuromodulation.
Goldman HB, Lloyd JC, Noblett KL, Carey MP, Castaño Botero JC, Gajewski JB, Lehur PA, Hassouna MM, Matzel KE, Paquette IM, de Wachter S, Ehlert MJ, Chartier-Kastler E, Siegel SW. Goldman HB, et al. Among authors: noblett kl. Neurourol Urodyn. 2018 Jun;37(5):1823-1848. doi: 10.1002/nau.23515. Epub 2018 Apr 11. Neurourol Urodyn. 2018. PMID: 29641846
Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder.
Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Berg KC, Kan F, Irwin CP. Siegel S, et al. Neurourol Urodyn. 2015 Mar;34(3):224-30. doi: 10.1002/nau.22544. Epub 2014 Jan 10. Neurourol Urodyn. 2015. PMID: 24415559 Free article. Clinical Trial.
International continence society best practice statement for use of sacral neuromodulation.
Goldman HB, Lloyd JC, Noblett KL, Carey MP, Casta Ño-Botero JC, Gajewski JB, Lehur PA, Hassouna MM, Matzel KE, Paquette IM, Wachter SG, Ehlert MJ, Chartier-Kastler E, Siegel SW. Goldman HB, et al. Among authors: noblett kl. Neurourol Urodyn. 2018 Jun;37(5):1821-1822. doi: 10.1002/nau.23596. Epub 2018 Apr 11. Neurourol Urodyn. 2018. PMID: 29641843 No abstract available.
Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
Noblett K, Siegel S, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Berg KC. Noblett K, et al. Neurourol Urodyn. 2016 Feb;35(2):246-51. doi: 10.1002/nau.22707. Epub 2014 Dec 24. Neurourol Urodyn. 2016. PMID: 25546568 Free article. Clinical Trial.
Neuromodulation.
Noblett K, Crowder C. Noblett K, et al. Obstet Gynecol Clin North Am. 2021 Sep;48(3):677-688. doi: 10.1016/j.ogc.2021.05.018. Obstet Gynecol Clin North Am. 2021. PMID: 34416945 Review.
50 results